Gliom kliniske forsøg i Maryland
11 studier for Gliom søger deltagere på steder i Maryland.
Byer i Maryland
Officiel studietekst (engelsk)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
RekruttererFase 1/2
12 Months – 21 Years · Alle køn · Opdateret 1. okt. 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Johns Hopkins Sidney Kimmel Cancer Center - Baltimore, Baltimore
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07326566Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1/2
Alder 18 til 99 · Alle køn · Opdateret 28. sep. 2026 · NCT07416188A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1/2
Alder 15 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT05588141Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- John Hopkins University, Baltimore
RekruttererFase 1
Alder 1 til 25 · Alle køn · Opdateret 18. aug. 2026 · NCT04485559Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1
Alder 18 til 120 · Alle køn · Opdateret 14. aug. 2026 · NCT06344130PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1/2
Alder 18 til 120 · Alle køn · Opdateret 12. aug. 2026 · NCT06161519A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- The John Hopkins Hospital, Baltimore
- Maryland Oncology Hematology- Columbia, Rockville
RekruttererFase 2
Alder 8 og opefter · Alle køn · Opdateret 27. jul. 2026 · NCT05503797LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
- Maryland Proton Treatment Center, Baltimore
- University of Maryland Greenebaum Cancer Center, Baltimore
- UCH Kaufman Cancer Center, Bel Air
- og 2 flere
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT04699773Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
- National Institutes of Health, Bethesda
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. dec. 2025 · NCT04541082Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas
- Rosy Njonkou Tchoquessi, Baltimore
RekruttererFase 1
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2025 · NCT04772456Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.